Table 1. Associations between Method of Nodule Discovery and Patient Features.
Patient Features | Median (range) or N (%) | P† | |||
---|---|---|---|---|---|
Radiographic incidentaloma | Palpated at sick/consult visit | Palpated at well exam | Discovered by family | ||
Patients | 26 (18%) | 20 (14%) | 38 (27%) | 57 (40%) | |
Age, yr | 15.8 (11.1–18.9) | 15.6 (6.6–18.9) | 15.3 (5.4–18.9) | 15.2 (5.5–18.9) | 0.78 |
Females:males | 17:9 (65:35%)* | 16:4 (80:20%) | 32:6 (84:16%) | 53:4 (93:7%)** | 0.009 |
Nodules ≥1 cm | 1 (1–2) | 1 (1–6) | 1 (1–3) | 1 (1–10) | 0.48 |
Dominant nodule diameter, mm | 14 (10–46)* | 21 (10–54) | 25 (12–42) | 28 (11–64)** | <0.0001 |
Thyroid cancer | 1 (4%)* | 6 (30%) | 13 (34%) | 14 (25%) | 0.02 |
Metastasis‡ | 0 (0%) | 2 (33%) | 7 (54%) | 9 (64%) | 0.69 |
Significantly lower or
significantly higher than in other groups, according to post-hoc comparison by Sidak-adjusted critical p-value (continuous variables) or cell-specific chi-squared statistic (categories).
Testing for equal distribution in all groups, including 4 patients with unknown method of discovery (data not shown), by Kruskal-Wallis test (continuous variables), or Fisher exact test (dichotomous features).
Among patients with thyroid cancer. All patients with “Metastasis” had lymph node metastases and, in addition, one child in the “Discovered by family” group also had diffuse pulmonary metastases.